Tafero EM Tablets contain Tenofovir Alafenamide and Emtricitabine, a fixed-dose combination of two nucleoside reverse transcriptase inhibitors (NRTIs) used in antiretroviral therapy. The combination works by blocking an enzyme needed by HIV for replication, helping reduce viral multiplication and supporting long-term control of HIV infection.

Benefits

• Helps control HIV-1 infection as part of combination therapy
• Supports reduction of viral replication
• Helps maintain healthy immune function
• Provides convenient once-daily combination treatment
• May be used in HIV prevention programs when prescribed appropriately

Active Ingredient

Tenofovir Alafenamide + Emtricitabine

Pack Size

30 Tablets

Indications

Tafero EM is indicated as part of antiretroviral therapy for HIV-1 infection and may also be used for HIV pre-exposure prophylaxis (PrEP) in eligible individuals. It should be taken only under the supervision of a qualified healthcare professional.

Directions for Use

Take Tafero EM once daily or as recommended by your healthcare provider. Swallow the tablet whole with water, with or without food, and maintain a consistent treatment schedule for the best results. Do not stop or change treatment without medical advice.